
### [NCIT:C139002](http://purl.obolibrary.org/obo/NCIT_C139002)
**Label:** Recurrent Soft Tissue Sarcoma

**Subclasses:** [NCIT:C7935](http://purl.obolibrary.org/obo/NCIT_C7935) (Recurrent Kaposi Sarcoma), [NCIT:C8803](http://purl.obolibrary.org/obo/NCIT_C8803) (Recurrent Extraskeletal Ewing Sarcoma), [NCIT:C8824](http://purl.obolibrary.org/obo/NCIT_C8824) (Recurrent Rhabdomyosarcoma), [NCIT:C8811](http://purl.obolibrary.org/obo/NCIT_C8811) (Recurrent Extraskeletal Osteosarcoma), [NCIT:C7822](http://purl.obolibrary.org/obo/NCIT_C7822) (Recurrent Adult Soft Tissue Sarcoma), [NCIT:C8067](http://purl.obolibrary.org/obo/NCIT_C8067) (Recurrent Childhood Soft Tissue Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 40.71%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39264](http://purl.obolibrary.org/obo/NCIT_C39264) (Angiogenesis Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39258](http://purl.obolibrary.org/obo/NCIT_C39258) (TPO Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39253](http://purl.obolibrary.org/obo/NCIT_C39253) (Interferon Signaling Modulation Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39250](http://purl.obolibrary.org/obo/NCIT_C39250) (Mucosal Healing Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39247](http://purl.obolibrary.org/obo/NCIT_C39247) (Telomere Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39246](http://purl.obolibrary.org/obo/NCIT_C39246) (T Cell Receptor Signaling Pathway BioCarta))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39236](http://purl.obolibrary.org/obo/NCIT_C39236) (Sprouty Regulation of Tyrosine Kinase Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39217](http://purl.obolibrary.org/obo/NCIT_C39217) (Ras Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39208](http://purl.obolibrary.org/obo/NCIT_C39208) (Rac1 Cell Motility Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39197](http://purl.obolibrary.org/obo/NCIT_C39197) (PPAR-alpha Gene Regulation Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39194](http://purl.obolibrary.org/obo/NCIT_C39194) (Phospholipase C Signaling Pathway))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39184](http://purl.obolibrary.org/obo/NCIT_C39184) (PDGF Signaling Pathway))) 39.90%


